- €33.15m
- €31.65m
- €15.73m
Brief: Biohit Distributor Invests In Production Capacity Increase
Brief: Biohit Signs Agreement For Distribution Of Acetium In Finland
Brief: Patent granted to Biohit Acetium capsule in Japan
Brief: Biohit H1 operating result swings to profit of EUR 7.4 mln
Brief: Biohit H2 operating loss flat at EUR 1.3 mln
Brief: Biohit: Ownership arrangement in Chinese JV, 2017 operating result to be positive
Brief: Biohit and R-kioski to start cooperation
Brief: Biohit's Chinese joint venture to start production
Brief: Glomedics to distribute Biohit lactose intolerance test in South Korea
Brief: Biohit signs distribution deal for GA-map dysbiosis test in China
Brief: Biohit H1 operating loss widening to SEK 2.1 million
Brief: Biohit: Simultaneous testing of GastroPanel biomarkers is possible
Brief: Biohit: Population-based screening study for gastric cancer risk is completed
Brief: Biohit and Pyynikin Craft Brewery to start cooperation
Brief: Biohit signs distribution agreement with Pooyandegan Pezeshki Pardis
Brief: Biohit report on smoking intervention trial accepted for publication
Brief: Biohit to distributute Biohit Calprotectin ELISA test in China
operation
Brief: Biohit Q4 operating loss continuing operations widens to EUR 1.4 million